您的购物车当前为空
别名 NOD1/2 拮抗剂-1
NOD1/2 antagonist-1 是一种双重抑制 nucleotide-binding oligomerization domain-like receptor NOD1 与 NOD2 的拮抗剂,对 NOD1 和 NOD2 的 IC50 分别为 1.13 μM 与 0.77 μM,半衰期为 67.6 分钟。NOD1/2 antagonist-1 可增强紫杉醇的抗肿瘤活性,是研究先天免疫受体信号通路及肿瘤调控的有力实验工具。


为众多的药物研发团队赋能,
让新药发现更简单!
NOD1/2 antagonist-1 是一种双重抑制 nucleotide-binding oligomerization domain-like receptor NOD1 与 NOD2 的拮抗剂,对 NOD1 和 NOD2 的 IC50 分别为 1.13 μM 与 0.77 μM,半衰期为 67.6 分钟。NOD1/2 antagonist-1 可增强紫杉醇的抗肿瘤活性,是研究先天免疫受体信号通路及肿瘤调控的有力实验工具。
| 规格 | 价格 | 库存 | 数量 |
|---|---|---|---|
| 1 mg | ¥ 3,570 | 现货 | |
| 5 mg | ¥ 7,880 | 现货 | |
| 10 mg | ¥ 10,800 | 现货 | |
| 25 mg | ¥ 16,100 | 现货 | |
| 50 mg | ¥ 21,300 | 现货 |
NOD1/2 antagonist-1 相关产品
| 产品描述 | NOD1/2 antagonist-1 is a dual inhibitor of nucleotide-binding oligomerization domain-like receptors NOD1 and NOD2, exhibiting IC50 values of 1.13 uM for NOD1 and 0.77 uM for NOD2, with an acceptable half-life of 67.6 minutes. NOD1/2 antagonist-1 enhances the antitumor efficacy of paclitaxel and serves as a potent experimental tool for investigating innate immune receptor-mediated signaling and cancer therapy modulation. |
| 靶点活性 | NOD1:1.13 μM, NOD2:0.77 μM |
| 体外活性 | NOD1/2 antagonist-1(0-10 μM,3小时)可对C12-iE-DAP诱导或MDP诱导的NF-κB活化产生抑制作用[1]。 |
| 体内活性 | 在B16荷瘤模型中,NOD1/2 antagonist-1(50 mg/kg,静脉注射,隔日一次,持续16天)显著提升了紫杉醇(PTX)的抗肿瘤效果[1]。 |
| 别名 | NOD1/2 拮抗剂-1 |
| 分子量 | 663.03 |
| 分子式 | C32H28ClF5N4O4 |
| CAS No. | 2704623-69-6 |
| Smiles | O=C(NCCCOC1=CC=C(C=C1)C(F)(F)F)C2=CC=3N=CN(C(=O)C3C=C2C=4C=CC=C(Cl)C4)CC(=O)N5CCCC(F)(F)C5 |
| 颜色 | White |
| 物理性状 | Solid |
| 存储 | store at low temperature | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. | |||||||||||||||||||||||||
| 溶解度信息 | DMSO: 25 mg/mL (37.71 mM), Sonication is recommended. H2O: < 1 mg/mL (insoluble), Sonication is recommended. | |||||||||||||||||||||||||
溶液配制表 | ||||||||||||||||||||||||||
DMSO
| ||||||||||||||||||||||||||
评论内容